These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1755332)

  • 21. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacogenetics and its importance in the clinical].
    Lares-Asseff I; Trujillo-Jiménez F
    Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and ethnic differences in warfarin response.
    El Rouby S; Mestres CA; LaDuca FM; Zucker ML
    J Heart Valve Dis; 2004 Jan; 13(1):15-21. PubMed ID: 14765833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of antidepressant drugs: pharmacogenetics.
    Sjöqvist F; Bertilsson L
    Adv Biochem Psychopharmacol; 1984; 39():359-72. PubMed ID: 6380229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic control of drug oxidation in the liver.
    Dayer P; Balant L; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):421-5. PubMed ID: 6147316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics: state of the research and perspectives in clinical application.
    Severino G; Chillotti C; Stochino ME; Del Zompo M
    Neurol Sci; 2003 May; 24 Suppl 2():S146-8. PubMed ID: 12811615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinically significant inherited differences in the mode of action of drugs].
    Meyer UA; Meier PJ
    Schweiz Med Wochenschr; 1982 May; 112(19):666-9. PubMed ID: 7100864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ethnic background related pharmacological differences].
    Reinbold H
    MMW Fortschr Med; 2007 Oct; 149(42):34, 36. PubMed ID: 17987717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
    Sjöqvist F; Bertilsson L
    Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic and clinical consequences of the genetic polymorphism of oxidation].
    Dayer P; Courvoisier F; Kupfer A; Balant-Gorgia A; Balant L; Fabre J
    Schweiz Med Wochenschr; 1983 Feb; 113(8):295-7. PubMed ID: 6133350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacogenetics and tailored drug treatment in schizophrenia].
    Andreassen OA; Steen VM
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In case of risks and side effects: ask your genes, too].
    Möritz A
    Med Monatsschr Pharm; 2007 May; 30(5):179-83. PubMed ID: 17526394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetic mechanisms underlying unanticipated drug responses.
    Carlquist JF; Anderson JL
    Discov Med; 2011 May; 11(60):469-78. PubMed ID: 21616045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited defects of hepatic drug metabolism.
    Küpfer A; Preisig R
    Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].
    Idle JR; Sloan TP; Smith RL; Wakile LA
    Br J Pharmacol; 1979 Jul; 66(3):430P-431P. PubMed ID: 526719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.